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NGF is implicated in retinal damage regression. To study whether this is a direct eﬀect or an eﬀect mediated by NGF on other
endogenous biological mediators, we investigated the eﬀect of exogenous administration of NGF in RCS rats aﬀected by retinitis
pigmentosa. We found that NGF administration exerts a rescue eﬀect on photoreceptors in this animal model. NGF injection
enhances brain-derived neurotrophic factor, b-ﬁbroblast growth factor, transforming growth factor-b, vascular endothelial factor
and neuropeptide-Y. This suggests that NGF has an eﬀect on RCS rat retina, probably also through the stimulation of other bio-
logical mediators produced and released in the retina.
 2005 Elsevier Ltd. All rights reserved.
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A number of recent studies have reported that the dif-
ferentiation, survival and function of retinal cells are
regulated by survival growth factors, including neuro-
trophins (Bagnoli, Dal Monte, & Casini, 2003; Chaum,
2003; Dyer & Cepko, 2001; Frade, Bovolenta, & Rodri-
guez-Tebar, 1999). We previously reported that injection
of NGF in CH3 mice delayed retinal degeneration and
suggested that a deﬁcit in the synthesis and/or release
of NGF might be implicated in the mechanism leading
to retinal degeneration (Lambiase & Aloe, 1996).
This hypothesis is supported by our recent studies
showing that cells of the visual system of Royal College
of Surgeons (RCS) rats aﬀected by inherited retinal cell0042-6989/$ - see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.visres.2004.12.020
* Corresponding author. Tel.: +39 06 8292592; fax: +39 06 86090370.
E-mail address: aloe@inmm.cnr.it (L. Aloe).degeneration (Gal et al., 2000) are characterized by a
signiﬁcant reduction of both NGF protein and mRNA
(Amendola & Aloe, 2002; Amendola, Fiore, & Aloe,
2003). Moreover, studies published in recent years have
raised the question of the eﬃcacy of a single growth fac-
tor and hypothesized the possibility of the overlapping
and/or cascading eﬀects triggered by one growth factor
on other growth factors can enhance the survival of in-
jured of retinal cells (Chaum, 2003; Ogilvie, Speck, &
Lett, 2000). Nonetheless, whether NGF has a direct ef-
fect on retinal cells or acts indirectly by stimulating
the synthesis and release of other growth factors has
not been clearly established.
Evidence obtained in animals with experimentally in-
duced retinal cell degeneration and in rodents with
inherited retinal deﬁcit, indicated that a number of sol-
uble factors, including brain derived neurotrophic fac-
tor (BDNF), b-ﬁbroblast growth factor (b-FGF),
transforming growth factor-b (TGF-b), tumor necrosis
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and neuropetide-Y (NPY) can, alone or together with
other growth factors, protects retinal cell degeneration
through mechanisms not yet clearly identiﬁed (Aloe
et al., 2001; Chaum, 2003; Dunker, Schuster, & Kriegl-
stein, 2001; Witmer, Vrensen, Van Noorden, & Schlin-
gemann, 2003). The aims of the present investigation
were to study the eﬀect of NGF on photoreceptors sur-
vival and on growth factors that have been suggested to
be involved in retinal cell development and retinal cell
survival, (Faktorovich, Steinberg, Yasumura, Matthes,
& LaVail, 1990; Liu & Regillo, 2004). To test our
hypothesis, NGF was injected in the retrobulbar space
of RCS rats during the third week of life. We selected
this stage on the basis of our previous studies indicating
that the degeneration of outer nuclear layer (ONL) in
the retina of RCS rats takes place between the second
and third week of life and that this structural ONL
reduction is associated with a steady decrease of
NGF (Amendola & Aloe, 2002). The results of the
present study indicate that the administration of NGF
during this critical period of retinal degeneration re-
tards retinal cell death and enhances the expression of
other survival growth factors produced locally. The
possible functional signiﬁcance of these ﬁndings will
also be discussed.2. Materials and methods
2.1. Animals
The RCS rats were originally obtained from Dr. R.
Hanitzsch from the Carl Ludwig Institute of Physiology,
University of Leipzig, Germany, and raised in our stab-
ularium as reported (Hanitzsch, Zeumer, Lichtenberger,
& Wurziger, 1998). All the rats used in our studies were
maintained on a 12 h light/dark cycle and provided with
food and water ad libitum. They were all killed in the
morning between 10:00 am and 12:00 am.
As regards housing, care and experimental proce-
dures we followed the indications set out by the Ethical
Commission on animal sperimentation of the CNR
(1992) in conformity with National and International
laws (EEC council directive 86/609, OJ L 358, 1, Decem-
ber 12, 1987). Moreover, all eﬀorts were made to mini-
mize animal suﬀering and to reduce the number of
animals used.
2.2. Chemicals
The NGF was isolated from the mouses submandib-
ular gland according to Bocchini and Angeletti method
(Bocchini & Angeletti, 1969). Polyclonal anti-mouse
NGF antibodies were prepared in rabbit, puriﬁed by a
process of aﬃnity chromatography and characterizedas described (Stoeckel, Gagnon, Guroﬀ, & Thoenen,
1976).
2.3. Treatments
Soon after delivery the number of newborn RCS rats
of each litter (n = 10) was reduced to 8 pups. Under
these conditions, pups develop somatic markers, such
as eyelid opening, tooth eruption and fur growth, at
the same age. At 18 days of age each litter was divided
in two experimental groups of four rats each. The ﬁrst
group of four rats received retrobulbar administration
of 5 lg of puriﬁed NGF dissolved in 5 ll of (0.09%
NaCl) physiological saline (PS), or 5 lg of cytochrome
C, a protein with the physiochemical properties and
molecular weight of NGF, but lacking biological activ-
ity (Aloe et al., 2001) diluted in 5 ll of PS, as controls.
All chemicals were delivered using a Hamilton microliter
syringer (Bonaduz, Switzerland) equipped with a needle
gauge 26 s. To assess whether the eﬀect of NGF was due
to injury-related eﬀect, ﬁve rats received the dry needle,
(size as above), insertion into the retrobulbar region and
the concentration of b-FGF, VEGF, TrkA and TNF-a
was measured.
To further investigate the role of NGF in the retina,
other rats (n = 8/group) received intravitreal administra-
tion of 10 lg of aﬃnity puriﬁed murine anti-NGF anti-
bodies raised in goat, dissolved in 5 ll of PS, or of 10 lg
of goat IgG, diluted in 5 ll of PS, and used as control.
As an additional control, a group of rats (n = 6) of
the same age received intravitreal insertion of a dry
needle.
The rats were treated every-other day for 8 days and
at 27 days of age they received an overdose of carbon
dioxide and their eyes were removed and used for struc-
tural, immunohistochemical, biochemical and molecular
analysis of the retina.
2.4. Morphological and Immunoﬂuorescence analysis
Eye bulbs were removed, ﬁxed with 4% paraformal-
dehyde dissolved in 0.1 M phosphate buﬀer, pH 7.4,
for 24 h and then left overnight in the same buﬀer con-
taining 20% of sucrose. The eyes were then sectioned
with a cryostate at 20 lm thick. The sections were cut
along the vertical meridian to include the full length of
the retina from the optic nerve head to the ora serrata.
Sections (n = 10) of each NGF-treated and untreated
rats, immunostained for the presence of NGF receptor
or stained with toluidine blue (not shown), were used
for a quantitative analysis to determine the mean thick-
ness of the ONL layer. The value of the ONL thickness
was obtained after measuring eight diﬀerent ﬁelds of
each retina under a Zeiss Axiphot microscope equipped
with a 20· objective with the aid of a computerized im-
age analysis system.
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retina
The retinas of the RCS rats treated with NGF, anti-
NGF-antibodies and respective controls were mounted
ﬂat on glass slides, air dried, and labeled with biotinyla-
ted Griﬀonia simplicifolia lectin B4 (Vector Laboratories,
CA, USA). The retinas were then exposed to rhoda-
mine-conjugated avidin (Vector Laboratories, CA,
USA). The stained retinas were then analyzed under a
Nikon microscope equipped with software LUCIA for
the quantitative evaluation of stained vessels. Blood ves-
sels present in 50 diﬀerent ﬁelds of diﬀerent retina
(n = 10) were counted and compared.
2.6. NGF assay
Retinas were homogenated and centrifuged at 8500 g
for 30 min. Polystyrene 96-well microtubes immuno-
plates (Nunc) were coated with aﬃnity puriﬁed poly-
clonal goat anti-NGF antibody, diluted in 0.05 M
carbonate buﬀer (pH 9.6). Parallel wells were coated
with puriﬁed goat IgG (Zymed, San Francisco, CA,
USA), for the evaluation of the non-speciﬁc signal. Fol-
lowing an overnight incubation at room temperature
and 2 h incubation with a blocking buﬀer (0.05 M car-
bonate buﬀer, pH 9.5, 1% BSA), the plates were washed
three times with Tris–HCl, pH 7.4 50 mM, NaCl
200 mM, 0.5% gelatin, 0.1% Triton X-100. After exten-
sive washing of the plates, the samples and the NGF
standard solution were diluted with a sample buﬀer
(0.1% Triton X-100, 100 mM Tris–HCl, pH 7.2,
400 mM NaCl, 4 mM EDTA, 0.2 mM PMSF, 0.2 mM
benzethonium chloride, 2 mM benzamidine, 40 U/ml
aprotinin, 0.05% sodium azide, 2% BSA and 0.5% gela-
tin), distributed into the wells and left at room temper-
ature overnight. The plates were then washed three
times and incubated with 4 mU/well anti-ﬂ-NGF-galac-
tosidase (Boehringer Mannheim, Germany) for 2 h at
37 C and, after further washing, 100 ll of substrate
solution (4 mg/ml of chlorophenol red, Boehringer
Mannheim, Germany, substrate buﬀer: 100 mM
HEPES, 150 mM NaCl, 2 mM MgCl2, 0.1% sodium
azide and 1% BSA) was added to each well. After an
incubation of 2 h at 37 C, the optical density was mea-
sured at 575 nm, using an ELISA reader (Dynatech),
and the values of standards and samples were corrected
by taking into consideration the non-speciﬁc binding.
Under these conditions the sensitivity was 3 pg/ml and
the recovery of NGF in our assay ranged from 80% to
90%. The recovery was estimated by adding to the retina
extracts a known amount of puriﬁed NGF and the yield
of the exogenous NGF was calculated by subtracting the
amount of this NGF from the endogenous NGF. Data
were represented as pg/g wet weight and all assays were
performed in triplicate.2.7. TGF-b1 protein determination
The quantiﬁcation of TGF-b1 was performed by
using a two-site enzyme immunoassay kit (DuoSet),
from R&D (Minneapolis, MN, USA) and following
the manufacturers instructions. TGF-b1 concentration
in the retina was expressed as pg/gr wet and all assays
were performed in triplicate.
2.8. Western blotting analysis for TrkA, TNF-a, VEGF
and b-FGF
The retinal tissue was homogenized in sample buﬀer
(0.01 M TRIS–HCl buﬀer pH 7.6, containing 0.25 M su-
crose, 0.1 M NaCl, 1 mM EDTA, and 1 mM PMSF)
and centrifuged at 8000g for 10 min at 4 C. The super-
natants were then used for western blotting. The sam-
ples (30 lg total protein) were dissolved with a loading
buﬀer (0.1 M TRIS-HCl buﬀer (pH 6.8) containing
0.2 M DTT, 4% SDS, 20% glycerol, and 0.1% bromo-
phenol blue), separated by 12.5% SDS-PAGE, and elec-
trophoretically transferred to a polyvinylidene ﬂuoride
membrane (PVDF) for 3 h. The membranes were incu-
bated for 40 min at room temperature with a blocking
buﬀer (10% non-fat dry milk, 10 mM TRIS pH 7.5,
100 mM NaCl, 0.1% Tween 20) and washed three times
for 10 min each at room temperature in Tris-buﬀered
saline and Tween (TTBS) (10 mM TRIS pH 7.5,
100 mM NaCl, 0.1% Tween 20). This was followed by
an incubation of 2 h at room temperature with anti-
TNF-a 1:500, anti-TrkA 1:500, anti-b FGF 1:1000
(provided by SantaCruz, CA, USA) anti-VEGF 1:500
(provided by Chemicon International, CA, USA). The
membranes were then washed three times for 10 min
each at room temperature in TTBS and incubated for
1 h with horseradish peroxydase-conjugated anti-rabbit
IgG (Cell Signalling, Beverly, MA, USA) as the second-
ary antibody. The blots were developed with an en-
hanced chemiluminescent (ECL) assay (Amersham
Bioscience, UK limited, England) as the chromophore.
The optical density of b-actin bands was used as an
internal control for diﬀerence in sample loading.
2.9. RT-PCR ELISA
mRNA expression levels were measured using a stan-
dardized RT-PCR method as previously described (Tir-
assa, Manni, Stenfors, Lundeberg, & Aloe, 2000).
Brieﬂy, the total RNA was extracted from the retina
by using the Chomczynski and Sacchi method (1987)
as modiﬁed in the TRIzol Kit (Gibco). Complementary
DNA (cDNA) was synthesized from 2 lg of the total
RNA using 200 Units of M-MLV reverse transcriptase
(Promega Italia, Milano, Italy) in 20 ll of total volume
reaction containing 250 ng Oligo (dT) 12–18 primer, 0.5
Units RNasin ribonuclease inhibitor and 0.5 mM dNTP
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KCl; 15 mM MgCl2; 50 mM DTT). The mixture was
incubated at 42 C for 1 h and the reaction was termi-
nated with a further incubation at 95 C for 5 min.
The housekeeping gene, glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), was co-ampliﬁed with TrkA,
BDNF, b-FGF, VEGF, NPY and used to normalize sam-
ple to sample variability. PCR ampliﬁcation was carried
out using a 50 ll reaction mixture containing: cDNA,
5 ll in 10· buﬀer, 200 mM dNTPs, 1.5 mM MgCl2, 2.5
Units of Taq DNA polymerase (Promega), 20 pmol of
trkA primers (50-CTCCTTCTCGCCAGTGG-30; 50-
GCTCCCACTTGAGAATG-30) or 20 pmol of BDNF
primers (50-AGCTGAGCGTGTGTGACAGT-30; 50-
TCCATAGTAAGGGCCCGAAC-30) or 10 pmol of
VEGF primers (50-CTCACCAAAGCCAGCACATA-
30; 50-ACCGCCTTGGCTTGTCACAT-30) or 20 pmol
of b-FGF primers (50-ACTTCAAGGATCCCAAGCG-
G-30; 50-TCAGTGCCACATACCAACTGG-30) or
15 pmol of NPY primers (50-CAGCAGAGGACATG-
GCCAGA-30; 50-GGGACAGGCAGACTGGTTTC-30)
and 3.12 pmol of GAPDH primers (50-CACCACCATG-
GAGAAGGCC-30; 50-CACCACCATGGAGAAGGC-
C-30). To allow the detection of PCR product by ELISA,
biotinylated primers were used. A sample containing all
the reaction reagents except cDNA was used as PCR neg-
ative control in any ampliﬁcation. Ten microlitres of 1:10
RT mixture without enzyme were used as further PCR
negative control. Themixtures were incubated for the indi-
cated cycles consisted of 1 min at 95 C, 1 min at 55 Cand
2 min at 72 C for 35 cycles in a GeneAmp PCR System
9700 (Applied Biosystems, CA, USA). The PCR products
were electrophorized in 2% agarose gel together with a
DNA ladder of 100 base pairs (GIBCO) and visualized
by ethidium bromide.
To assess the presence of these probes, the microplates
(MaxisorpNunc) were coated with 50 lg/ml of avidin (Sig-
ma Chemical, Italy) in a coating buﬀer (15 mM Na2CO3,
35 mM NaHCO3, pH 9.6), and incubated for 2 h at
37 C. After incubation free sites were saturated with 2%
blocking solution (Boheringer Mannheim) in a coating
buﬀer. Biotinylated PCR products diluted in PBS contain-
ing 3% Bovine Serum Albumin (PBSB) were distributed in
triplicate (100 ll/well) in avidin-coated microplates and
incubated for 1 h at room temperature. After incubation
the microplates were washed three times with PBS contain-
ing 0.02% Tween 20 (a washing buﬀer). The DNA was
denatured using 0.25 M NaOH at room temperature for
10 min, then 100 ll/well of 4 pmol/ml digoxygenin-labelled
probes of TrkA (50-TGAAGTACTGTGGGTTCTC-
GATGATGTGGC-30), BDNF (50-TAACCCATGGG-
ATTACACTTGGTCACGTAG-30), VEGF (50-GTTCT-
ATCTTTCTTTGGTCTGCATTCACAT-30), b-FGF (50-
GCAGTACAGCCGCTTGGGATCCTTGAAGTG-30),
NPY (50-GAGGTCTGAAATCAGTGTCTCAGGGCT-
GGA-30) and GAPDH (50-ACAATCTTGAG- TGAGT-TGTCATATTTCTCG-30) in DIG Easy Hybri- dization
buﬀer (Boehringer Mannheim) were added and incubated
at 42 C for 2 h. After washing, anti-digoxygenin POD-
coupled antibody (Boehringer Mannheim) was added
(1:1000 in PBSB) and incubated for 1 h at 37 C. The
reaction was developed by TMB (3,30,5,50-tetramethyl-
benzidine; 0.6 mg in citrate buﬀer, pH 5.0) and blocked
after 30 min with 2 M HCl. The amount of ampliﬁed
products was measured as optical density at 450/690 nm
(OD, 450/690) using a Dynatech ELISA Reader 5000.
GAPDH (OD, 450/690) level was used to normalize the
relative diﬀerences in sample size, integrity of the
individual RNA and variations in reverse transcription
eﬃciency.
2.10. Statistical analysis
The analysis of variance (ANOVA) was used to ana-
lyze ONL thickness and neurotrophins, growth factors
and cytokines levels in the retinas of the RCS rats. Post
hoc comparisons within logical sets of means were per-
formed using the Tukey-Kramer test.3. Results
3.1. General observations
No somatic diﬀerences were found between NGF-
treated and anti-NGF treated RCS rats compared to
respective controls. Body weight, time of eye opening,
tooth eruption, and weaning schedules were not diﬀer-
ent. Moreover, the mean weight of the eye cup was sim-
ilar between groups (data not shown).
3.2. Eﬀect of NGF on TrkA in the retina
To explore whether retinal cells were receptive to
NGF, NGF or anti-NGF antibody were injected in
the retrobulbar and intravitreal region.
The results show that injection of NGF causes a
marked increase of TrkA protein in the retinal tissues
of the RCS rats as shown in Fig. 1A. NGF administra-
tion also induces an upregulation of TrkA mRNA levels
in the retinas of the RCS rats (Fig. 1B), compared to
cytochrome C treated rats (p < 0.05).
This observation is consistent with other previous re-
ports which showed that retinal cells are receptive to the
action of NGF (Amendola et al., 2003).
3.3. Eﬀect of NGF on ONL thickness
NGF untreated RCS rats show a progressive reduc-
tion of the ONL leading to retinal degeneration. The
thickness of ONL was measured and used as an index
of photoreceptor loss of the retina in treated and un-
Fig. 1. Protein and mRNA for TrkA. (A) shows the results of western
blot analysis for the TrkA protein in the retina of cytochrome C (CY,
control) and of NGF treated RCS rats. b-actina was used as the
internal control. (B) illustrates the RT-PCR ELISA expression for
TrkA in the retina of cytochrome C and of NGF treated RCS rats.
Data represents mean levels ± SD. Asterisks indicate signiﬁcant
diﬀerences between groups (p < 0.05, in the ANOVA).
Fig. 2. Immunoﬂuorescence for TrkA and quantitative analysis of the ONL
RCS rats treated with cytochrome C (A), NGF (B), IgG (C) or anti-NGF (D
retina of NGF treated rats as compared to cytochrome C, and a decrease of t
These diﬀerences are statistically signiﬁcant (E, p < 0.01).
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treated RCS rats retinas was 81.8 ± 2.44 lm, while it
was 56.3 ± 3.71 lm (p < 0.01) in the untreated retinas
and 30.4 ± 6.17 lm (p < 0.0001) in the anti-NGF treated
retinas. In the IgG-treated retinas it was
59.5 ± 10.26 lm, as shown in Fig. 2.3.4. Eﬀect of NGF on retinal blood vessels
Since retinal cell survival is associated with the pres-
ence of blood vessels, the retinas of NGF-treated and
untreated rats were isolated and used to evaluate the dis-
tribution of retinal blood vessels. As reported in Fig. 3A
and B, NGF reduces the loss of blood vessels in the ret-
ina of RCS rats, and, as shown in Fig. 3C, this diﬀerence
is statistically signiﬁcant (p < 0.01).3.5. Eﬀect of NGF or anti-NGF administration on
retinal BDNF presence
Because BDNF has been shown to be involved in
promoting the recovery of injured retinal cells (Krue-
ger-Naug, Emsley, Myers, Currie, & Clarke, 2003), wethickness. (A)–(D) illustrate TrkA immunoreactivity in the retina of
) treated RCS rats. Note the increase of the photoreceptor ONL in the
he ONL thickness after anti-NGF administration as compared to IgG.
Fig. 3. Qualitative and quantitative evaluation of blood vessels. (A)–(C) report qualitative and quantitative evaluation of blood vessels present in the
retinas of cytochrome C (A) and NGF treated (B) RCS rats. These ﬁgures indicate that the blood vessels of the retinas, immunostained with
biotinylated Griﬀonia simplicifolia lectin, are more numerous in NGF-treated rats, compared to control ones. The quantitative determination shown
in (C) indicates that this increase is statistically signiﬁcant (p < 0.01).
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ence. As shown in Fig. 4A, NGF enhances the concen-
tration of BDNF protein compared with the control
retinas. This eﬀect seems functionally relevant, since
anti-NGF administration down-regulates BDNF gene
expression (p < 0.05, Fig. 4B).Fig. 4. Protein and mRNA for BDNF. (A) shows the BDNF protein level in
of BDNF is represented as means values ± SD and the asterisks indicate the si
the RT-PCR ELISA expression for BDNF in the retina of RCS rats treated w
asterisks indicate signiﬁcant diﬀerences between the two groups (p < 0.05, in3.6. Eﬀect of NGF or anti-NGF administration on
b-FGF presence
As shown in Fig. 5A and B, the retrobulbar adminis-
tration of NGF causes an increase in b-FGF protein and
mRNA expression compared to cytochrome C injectedthe retina of controls and of NGF treated RCS rats. The concentration
gniﬁcantly enhance of BDNF in NGF-treated rats (p < 0.05). (B) shows
ith either IgG or anti-NGF. Data represents mean values ± SD and the
the ANOVA).
Fig. 5. Protein and mRNA for b-FGF. (A) shows the results of
western blot analysis for b-FGF in the retinas of control and NGF
treated RCS rats. The picture of b-actina is shown as normalization.
(B) and (C) illustrate RT-PCR ELISA expression for b-FGF in the
retinas of RCS rats treated with NGF (B), or with anti-NGF (C). Data
are expressed as mean levels ± SD. b-FGF increases in the retina of
NGF treated rats (p < 0.01) compared to cytochrome C injection,
while it decreases in the anti-NGF treated rats compared to IgG
injection.
Fig. 6. mRNA for NPY. (A) and (B) show the RT-PCR ELISA
expression for NPY in the retinas of RCS rats treated with NGF (A),
or with anti-NGF (B). Data are expressed as mean levels ± SD.
Asterisks indicate a signiﬁcant increase (A), and decrease (B) in NPY
expression compared to their respective controls (p < 0.05).
Fig. 7. Protein and mRNA for VEGF. (A) and (B) show respectively
western blot analysis and RT-PCR ELISA for VEGF in the retina of
RCS rats treated either with cytochrome C or NGF. Data on the
VEGF mRNA expression represent mean levels ± SD. Asterisks
indicate signiﬁcant diﬀerences between the two groups (p < 0.05).
Both VEGF mRNA and protein increased after the treatments.
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ies leads to a decrease of b-FGF gene expression, com-
pared to IgG injected rats (p < 0.01, Fig. 5C).
3.7. Eﬀect of NGF or anti-NGF administration on
retinal NPY presence
NPY is a neuropeptide that has been shown to be
present in retinal tissues and the brains visual projection
(Aloe et al., 2001). As reported in Fig. 6A and B, the
administration of NGF enhances gene expression, while
the anti-NGF antibody reduces it. This diﬀerence is sta-
tistically signiﬁcant (p < 0.05).
3.8. Eﬀect of NGF or anti-NGF administration on
retinal VEGF presence
VEGF has also been found in the retina and it is
known to promote the development of rat photorecep-
tor cells (Witmer et al., 2003). As reported in Fig. 7,the administration of NGF causes an increase in
both VEGF protein (Fig. 7A) and VEGF gene expres-
sion (Fig. 7B) in the retina of RCS rats and this diﬀer-
ence is statistically signiﬁcant compared to control
(p < 0.05).
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TGF-b is a survival factor present in the retina that
has been tested for treatment of macular holes and as
survival factor on in vitro retinal cells (Dunker et al.,
2001; Glaser, Michels, Kuppermann, Sjaarda, & Pena,
1992). As reported in Fig. 8A, an immunoenzymatic
analysis showed that treatment with NGF causes a sta-
tistically signiﬁcant (p < 0.01) increase of TGF-b protein
in the retina of the RCS rats.
3.10. Eﬀect of NGF on TNF-a level
To investigate whether an injection of NGF enhanced
the expression of pro-inﬂammatory cytokines, we tested
the eﬀect of NGF on the presence of TNF-a. As shown
in Fig. 8B, NGF has no eﬀect on TNF-a protein release.
3.11. Eﬀect of dry needle injection
Since it has been reported that needle insertion in the
subretinal region can produce a rescue eﬀect on photo-Fig. 8. Protein for TGF-b and western blotting analysis for TNF-a.
(A) shows the concentration of TGF-b protein in the retina of control
and NGF treated rats, TGF-b levels are remarkably enhanced in the
retina of NGF injected rats. Data represents mean values ± SD, the
asterisks indicate signiﬁcant diﬀerences between the two groups
(p < 0.01). (B) shows the result of western blot analysis for TNF-a
and b-actina as internal control of the assay. Note the enhanced
expression of TNF-a in the retina of the treated RCS rats.
Fig. 9. Eﬀect of dry needle injection. The ﬁgure shows the eﬀect of dry
needle insertion on the retinal levels of TrkA b-FGF, VEGF, and
TNF-a. The results of western blotting analysis revealed that there are
no diﬀerences between needle inserted in the retrobulbar (NI-R), or
intravitreal (NI-I) and uninjected eye (UN), suggesting that needle
insertion by itself in these two ocular regions do not induce an eﬀect
similar to that of NGF.receptor cells (Faktorovich, Steinberg, Yasumura, Mat-
thes, & LaVail, 1992), we measured the concentration
of TrkA, b-FGF, VEGF and TNF-a in rats receiving
only a dry needle injection in the retrobulbar or intravi-
treal regions. As reported in Fig. 9, western blotting
analysis revealed that retinal injury induced by retrobul-
bar (NI-R) or intravitreal (NI-I) dry needle insertion,
did not cause TrkA, b-FGF, VEGF and TNF-a protein
increase.4. Discussion
The purpose of the present study was twofold: ﬁrst to
investigate the eﬀect of retrobulbar administration of
NGF on photoreceptor cell survival and second, to ex-
plore whether the administration of NGF inﬂuences
the local synthesis and release of other growth factors
involved in the survival and function of the retinal cells.
L. Lenzi et al. / Vision Research 45 (2005) 1491–1500 1499The results demonstrated that injection of NGF en-
hances the expression of high-aﬃnity NGF receptor
proteins and of their mRNA in the retina of RCS rats,
suggesting that retinal cells are receptive to the action
of NGF. Moreover, it was found that the administration
of NGF, given during a critical stage of retinal degener-
ation, could signiﬁcantly reduce retinal cell death. Thus
the evidence that NGF stimulates the synthesis and re-
lease of other endogenous growth factors, including b-
FGF, BDNF, TGF-b and VEGF, known to be involved
in the delay or prevention of retinal cell degeneration,
support the hypothesis of the role of NGF as cell retinal
survival factor. The immunohistochemical analysis per-
formed on NGF-treated and untreated rats indicated
that the photoreceptor layer and the ONL thickness
are larger than those of NGF-untreated rats, suggesting
as previously reported that NGF given to CH3 mice
(Lambiase & Aloe, 1996) and to RCS rats (Amendola
& Aloe, 2002; Amendola et al., 2003) protects the retinal
cells from degeneration. This hypothesis is strengthened
by the observation that administration of anti-NGF
antibody, which inhibits the biological activity of the
endogenous produced NGF, exacerbates the degenera-
tive course of RGCs (Lambiase & Aloe, 1996). Our ﬁnd-
ings also showed that NGF injection causes not only an
increase of the FGF-b, BDNF, VEGF proteins, but also
an overexpression of their m-RNAs. This eﬀect seems
functionally relevant, since the administration of anti-
NGF antibodies signiﬁcantly reduces the expression of
these growth factors in the retina. Moreover, we found
that NGF stimulates retinal TGF-b and NPY, but not
TNF-a, a pro-inﬂammatory cytokine also present in
the retina. Further evidence suggesting a functional role
of NGF on retinal cells, is that the administration of
NGF protects blood vessels loss in the retinas of the
RCS rats. The eﬀect of NGF on vascular endothelial
cells and blood vessels has been recently reported, both
in rodents (Emanueli et al., 2002) and in humans (Fos-
ter, Costa, Poston, Hoult, & Brain, 2003).
It has been reported that retinal injury caused by nee-
dle insertion can also aﬀect the synthesis and release of
growth factors and to rescue damaged photoreceptors
(Faktorovich et al., 1992). The observation that dry nee-
dle insertion by itself does not reproduce the eﬀect of
NGF on b-FGF, VEGF, TrkA, suggests that the eﬀect
of NGF on these survival factors are due to NGF but
not to retinal injury (Faktorovich et al., 1992). This
hypothesis is also suggested by evidence that NGF
administration and needle insertion do not stimulate
TNF-a release.
We have previously shown that NGF can delay reti-
nal cell degeneration in C3H mice and that early NGF
treatment induces a delay in the evolution of retinal
degeneration, signiﬁcantly increasing the thickness of
the ONL and reducing the extension of retinal degener-
ation (Lambiase & Aloe, 1996). The fact that NGFundergoes a dramatic decrease during postnatal life in
the retina of RCS rats (Amendola et al., 2003) and that
the administration of NGF during a critical period of
retinal cell degeneration delays cell death (Lambiase &
Aloe, 1996) indicates that NGF loss might be one cause
or a contributing factor of retinal degeneration. The
mechanism through which NGF exerts its survival ac-
tion is not clearly known. As NGF is known to play a
marked role in the prevention of cell apoptosis, our
working hypothesis is that NGF acts on the modulation
of other survival factors, such as b-FGF, NPY, VEGF,
TGF-b, BDNF. The observation that NGF exerts a pro-
tective and/or survival action on retinal cells is in line
with other previous ﬁndings (Amendola et al., 2003;
Lambiase & Aloe, 1996; Siliprandi, Canella, & Carmig-
noto, 1993). It is therefore possible that the administra-
tion of NGF during a critical period of retinal cell
degeneration, alone or in combination with other bio-
logical mediators, might delay retinal cell death in gene-
tic and not genetically induced retinal cell degeneration.
Using this or other animal models of RP, it would be
of interest to determine whether or not a prolonged
NGF exposure and/or the co-administration of multiple
factors could provide additional synergistic beneﬁts.Acknowledgments
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